Chemomab Therapeutics Ltd. Key Management Personnel Compensation Postemployment Benefits
Chemomab Therapeutics Ltd. (CMMB) reported Key Management Personnel Compensation Postemployment Benefits of $13.00 thousand for the 12-month period ending 2018-12-31, per its 20-F filed 2019-04-24.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits · last filed 2019-04-24
| Period end | Key Management Personnel Compensation Postemployment Benefits 12 month |
|---|---|
| 2018-12-31 | $13.00K 20-F · filed 2019-04-24 |
| 2017-12-31 | $13.00K 20-F · filed 2019-04-24 |